Coya Therapeutics, Inc（COYA）美股招股说明书 S-1 （2022-11-18首版）（英文版）（197页）.pdf

1、S-1 1 coya-s1.htm S-1As filed with the Securities and Exchange Commission on November 18,2022Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933COYA THERAPEUTICS,INC.(Exact Name of Registrant as Specifie

2、d in Its Charter)Delaware 2834 85-4017781(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.Employer IdentificationNumber)Coya Therapeutics,Inc.5850 San Felipe St.Suite 500Houston,TX 77057(800)587-8170(Address,Including Zip Code

3、,and Telephone Number,Including Area Code,of Registrants Principal Executive Offices)Howard BermanChief Executive OfficerCoya Therapeutics,Inc.5850 San Felipe St.Suite 500Houston,TX 77057(800)587-8170(Name,Address,Including Zip Code,and Telephone Number,Including Area Code,of Agent For Service)Copie

4、s to:Michael J.LernerSteven M.SkolnickLowenstein Sandler LLP1251 Avenue of the AmericasNew York,New York 10020(212)262-6700 Stephen E.OlderDavid S.WolpaMcGuireWoods LLP1251 Avenue of the Americas,20th FloorNew York,New York 10020212-548-2100 Approximate date of commencement of proposed sale to the p

5、ublic:As soon as practicable after the effective date of this Registration Statement.If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of1933,check the following box.If this form is filed to registe

6、r additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check the following box and list theSecurities Act registration statement number of the earlier effective registration statement for the same offering.If this form is a post-effective amendment filed pursuant to